SUCRAFINE-O Suspension is an effective gastroprotective formulation from Orfit Pharmaceutical Pvt. Ltd., developed to provide relief from acid-related disorders of the stomach and upper gastrointestinal tract. It contains Sucralfate 1 gm, which forms a protective barrier over ulcers and inflamed mucosa, along with Oxetacaine 20 mg, a local anesthetic that helps reduce pain and discomfort caused by excess gastric acid. This suspension is commonly prescribed for the treatment of gastric and duodenal ulcers, gastritis, gastroesophageal reflux disease, and acid peptic disorders associated with burning sensation, epigastric pain, and irritation. Sucralfate adheres to the ulcer surface and protects it from acid, pepsin, and bile salts, promoting natural healing, while oxetacaine provides rapid relief from pain by numbing the gastric lining. SUCRAFINE-O Suspension offers both protective and symptomatic relief, making it especially beneficial for patients experiencing severe acidity and ulcer-related discomfort. The liquid formulation ensures uniform coating of the gastric mucosa and ease of administration. Manufactured under strict quality and safety standards, SUCRAFINE-O reflects Orfit Pharmaceutical Pvt. Ltd.’s commitment to delivering reliable, effective, and patient-friendly solutions for gastrointestinal care.